| |
Rx COMMUNICATIONS GROUP LAUNCHES RxIR USA®,
A NEW INVESTOR RELATIONS SERVICE FOR NON-U.S. LISTED FOREIGN
LIFE SCIENCE COMPANIES
FOR INQUIRIES CONTACT
Pete Holmberg, Vice President
Rx Communications Group, LLC
917-322-2164
pholmberg@rxir.com
New York, NY, March 12, 2003 -- Rx Communications Group, LLC, a financial communications firm specializing in the life science and healthcare industries, today announced the launch of a new service to address the needs of internationally domiciled life science companies seeking a presence in the U.S. capital markets. RxIR USAÒ is a tactical, annual investor relations program devised to help foreign companies begin to build awareness of their corporate story among key U.S. investment and media industry influencers.
“We developed this program in response to the growing interest of foreign companies that don't yet require a full-fledged U.S. investor relations effort, but nonetheless are very interested in forging relationships with American investors,” said Rhonda Chiger, Co-President of Rx Communications Group, LLC. “While the U.S. has always been acknowledged as being the largest biotechnology arena in the world, international life science companies are now increasingly recognizing the global influence of the U.S. market and are seeking ways to tap into it. This is where the RxIR USAÒ program fills a void – by providing an efficient and effective program that delivers results, while also being sensitive to clients’ time constraints and budgets.”
For an annual fixed cost, RxIR USAÒ provides the essentials of a U.S. investor relations effort. Unlike Rx Communications’ full service offering, RxIR USA® is a tactical, pre-fixed program implemented by seasoned investor relations professionals who are specialists in the life science and healthcare industries. Clients will have access to services that include press release editing and distribution, conference call coordination, investor meetings, as well as market intelligence and industry feedback.
“While Rx Communications’ core competency remains its ability to provide high-level strategic counsel, we realized the need for a tactical approach that helps foreign companies begin to skim the surface in reaching out to the U.S. investment community,” said Melody A. Carey, Co-President of Rx Communications Group, LLC. “We launched this firm with the goal of helping life science and healthcare companies both here and abroad throughout all stages of their development, to most effectively communicate their stories to key constituents. RxIR USAÒ is a natural extension of our already established service offering and will enable select international companies to gain a much-needed foothold in the U.S. market.”
Rx Communications Group, LLC is a financial communications firm specializing in the life science and healthcare industries. Rx provides investor relations, media relations and corporate communications counsel to private and public companies, worldwide. The firm designs, implements and manages full-service programs, and handles transaction-oriented assignments. Rx executives are well versed in IPOs, secondary offerings, PIPEs, venture rounds and mergers and acquisitions. RxIR USAÒ is a service of Rx Communications geared toward non-U.S. listed public foreign companies seeking to reach U.S. investors. For more information about Rx Communications visit the company’s website at www.RxIR.com.
|
|
